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Objective: To assess the incidence, costs, and mortality associated with chronic critical illness
(CCI),  and to identify clinical predictors of CCI in a general intensive care unit.
Methods: This was a prospective observational cohort study. All patients receiving supportive
treatment for over 20 days were considered chronically critically ill and eligible for the study.
After applying the exclusion criteria, 453 patients were analyzed.
Results: There was an 11% incidence of CCI. Total length of hospital stay, costs, and mortality
were signiﬁcantly higher among patients with CCI. Mechanical ventilation, sepsis, Glas-
gow score < 15, inadequate calorie intake, and higher body mass index were independent
predictors for CCI in the multivariate logistic regression model.
Conclusions: CCI affects a distinctive population in intensive care units with higher mortality,
costs,  and prolonged hospitalization. Factors identiﬁable at the time of admission or during
the  ﬁrst week in the intensive care unit can be used to predict CCI.
       
Predic¸ão  de  doenc¸a crítica  crônica  em  uma  unidade  geral  de  cuidados
intensivos
alavras-chave:
oenc¸a crítica
r  e  s  u  m  o
Objetivo: Avaliar a incidência, custos e mortalidade relacionados a doenc¸a crítica crônica
(DCC) e identiﬁcar seus preditores clínicos em uma unidade de terapia intensiva geral.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDuma coorte observacional prospectiva. Todos pacientes que recebiamentilac¸ão mecânica prolongada Métodos: Trata-se de 
ontrole de custos
ortalidade hospitalar
tratamento de suporte por mais de 20 dias eram considerados doentes críticos crônicos.
Permaneceram 453 pacientes após a aplicac¸ão dos critérios de exclusão.
Resultados: A incidência de DCC foi de 11%. Permanência hospitalar, custos e mortalidade
foram signiﬁcativamente maiores na populac¸ão com DCC. Ventilac¸ão mecânica, sepse,
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Glasgow escore < 15, inadequada ingestão calórica e elevado índice de massa corporal foram
preditores independentes para DCC em um modelo multivariado de regressão logística.
Conclusão: DCC abrange uma distinta populac¸ão nas unidades de terapia intensiva apresen-
tando maiores mortalidade, custos e permanência hospitalar. Alguns fatores presentes na
admissão ou durante a primeira semana na unidade de terapia intensiva podem ser usados
como preditores de DCC.
13 EIntroduction
Chronic critical illness (CCI) is deﬁned by a prolonged depend-
ence on life support. Transition from acute to chronic phase
is often difﬁcult to perceive in critically ill patients. One of the
most common parameters used to deﬁne CCI is the need for
prolonged mechanical ventilation (MV) or for tracheotomy.1–5
Thus, CCI may be understood as an inadvertent outcome
of technological advances used in the intensive care unit
(ICU). In this scenario, patients survive an acute incident but
still require prolonged life-support,2,6 leading to a population
with different pathophysiological characteristics from those
of an acute ICU patient. Neuroendocrine,7,8 metabolic,9–11 and
neuromuscular12,13 adaptations are reported with an inci-
dence of 5% to 20%.6,14–16 This population is also characterized
by increased in-hospital and post-hospital mortality,14,17–22
elevated costs,22,23 and signiﬁcant dependence on social
assistance, with frequent re-hospitalizations, home care, or
institutionalization.14,17,20 The annual per capita cost of these
patients ranges from US$200,000 to US$500,000, representing
a potential public health problem.2,22,23 The purpose of this
study was to assess the incidence, costs, and mortality asso-
ciated with CCI, and to identify early predictors of CCI in a
general ICU.
Material  and  methods
Study  design
A prospective cohort study was conducted at the ICU of Hospi-
tal Mãe  de Deus, a general private hospital located in Southern
Brazil, with 32 beds occupied by medical and surgical patients.
The inclusion criteria were all patients admitted in ICU (from
June 1 to November 30, 2008), with the intention of comparing
critically ill with chronic critically ill patients. The exclusion
criteria were patients under the age of 18 years (9 patients),
length of stay under 48 hours in the unit (172 patients), and
patients with do not resuscitate orders (3 patients). Three
missing cases were excluded. Four hundred and ﬁfty-three
patients were effectively followed-up.
This study was approved by the Institutional Review Board
of Hospital Mãe  de Deus, and registered in the Brazilian
National System of Research and Ethics, under protocol num-
ber 0067.0.111.000-07.
© 20Deﬁnitions  and  outcomes
Patients were classiﬁed as critically ill or chronically critically
ill. The latter were deﬁned as patients who remained in the        
ICU for over 20 days due to the need of mechanical ventilation
or hemodynamic support. The main endpoints of the study
were length of stay, hospital costs, and mortality.
The following variables were assessed and registered for
each patient: presence of prior chronic disease (chronic pul-
monary obstructive disease; cardiac insufﬁciency; ischemic
heart disease; renal disease; neuromuscular dysfunction
[patients with major functional limitations such as secondary
sequelae of stroke, paraplegia, quadriplegia, primary myopa-
thy, degenerative diseases of the central nervous system
determinants of muscle dysfunction]; severe psychiatric disor-
der [severe bipolar disorder, major depression, illicit drug use,
schizophrenia]; dementia [signiﬁcant cognitive disabilities
registered or documented in the medical record, associated
with degenerative diseases of the central nervous system or
sequelae of stroke]; and diabetes), body mass index (BMI), sys-
temic inﬂammatory response syndrome (SIRS, deﬁned as two
or more  of the following: body temperature less than 36 ◦C
or greater than 38 ◦C; heart rate greater than 90 beats per
minute; tachypnea, with greater than 20 breaths per minute
or, an arterial partial pressure of carbon dioxide less than
32 mmHg; white blood cell count less than 4,000 cells/mm3
or greater than 12,000 cells/mm3; the presence of greater
than 10% immature neutrophils), sepsis (two SIRS criteria
associated with proven or very probable infection), organ dys-
function in the ICU, acute physiology and chronic health
evaluation II (APACHE II) score, sequential organ failure assess-
ment (SOFA) score, laboratory tests, nutritional intake, and
admission diagnosis. Readmission to the ICU was deﬁned as
a new admission occurring after 24 hours following discharge.
The occurrence of any accident or unfavorable event in the
ICU was also monitored; these were called adverse events and
included urinary tract infection, catheter, probe or drain loss,
and procedure-related complications. Inadequate nutritional
intake was deﬁned as a protein-calorie intake of less than 60%
of that required, without a medical justiﬁcation (such as inter-
ruption of feeding for procedures or transportation). Patients
were considered hyperglycemic whenever at least half of the
capillary or venous glucose measurements of the day reached
more  than 180 mg%. Body mass index (BMI) was calculated
based on measured weight and height.
The following variables were collected and monitored
(monitored daily, when appropriate): patient’s name, age,
gender, diagnosis at ICU admission, pre-ICU length of hos-
pitalization, previous chronic disease, BMI, readmission after
ICU discharge, surgery, APACHE II score, SOFA score, capillary
glucose, sepsis, MV, hemodialysis, corticotherapy, use of intra-
venous insulin, need for vasopressor and/or inotropic agents,
lsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDblood or blood products transfusions, laboratory results,
enteral and/or parenteral nutrition (and caloric intake), intra-
venous sedation, cardiopulmonary resuscitation, pressure
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lcer, adverse events (accidental loss of probes or drain tubes
nd accidental extubation), do not resuscitate order, ICU and
ospital length of stay, hospital approved costs, and survival
r death.
tatistical  analysis
escriptive statistics (mean, standard deviation, absolute and
elative frequencies) were calculated. Odds ratios (OR) and 95%
onﬁdence interval (95% CI) were calculated to estimate the
agnitude of associations. Student’s t-test for two indepen-
ent samples and the chi-squared test were used to assess
ean differences between groups. Assumptions of homo-
eneity of variance and normality were examined prior to
esting (and a parametric or nonparametric test was chosen).
 logistic regression model was constructed to determine pre-
ictors of CCI. A p-value of less than 0.05 was considered as
igniﬁcant. All variables that were predictive (p < 0.20) in the
nivariate analysis were entered into the logistic regression
odel. In the multivariate procedure, p < 0.05 was considered
s the level of signiﬁcance. The ﬁnal model was constructed
ith a backward method following Wald’s criterion and apply-
ng the “1 to 10” rule. Model adjustment and calibration were
espectively evaluated with receiver operating characteris-
ic (ROC) curve and Hosmer-Lemeshow goodness-of-ﬁt test,
espectively. Statistical analysis was performed with the Sta-
istical Package for Social Sciences (SPSS) version 16 software.
esults
able 1 summarizes the presentation and outcome of criti-
ally ill and chronically critically ill patients. The incidence of
CI was 11%, or 50 out of the 453 patients studied. Of these,
2 (84%) cases were due to prolonged mechanical ventilation,
nd eight (16%) were due to the need for intensive monitoring
r inotropic and/or vasopressor infusion. There was no dif-
erence between the two groups regarding previous disease,
xcept for higher incidence of prior neuromuscular disease in
he CCI group (OR = 4.21, 95% CI: 1.63-10.9, p = 0.003).
Among patients with CCI, 38 had a tracheotomy (76%),
erformed on average 16.8 ± 8.1 days after admission. There
as no difference between groups regarding the development
f renal dysfunction, hepatic dysfunction, thrombocytopenia,
ays of fasting, and need for parenteral nutrition. Pressure
lcers occurred more  frequently among patients with CCI
51.9%) than in the non-CCI group (6%) (p < 0.001), and were
ore  often observed after the ﬁrst ten days in the ICU. The
OFA score varied signiﬁcantly between groups; however, the
aily variation of the score was not signiﬁcant between CCI
nd non-CCI patients. The total cost of chronically critically
ll patients was US$ 9,174,852.00 (50 patients), while the cost
or critically ill patients was US$ 13,408,495.00 (403 patients).
able 1 shows the mean per capita cost for the two groups.
Among the 50 patients with CCI, 29 died during hospi-
alization (58%). Regarding previous chronic morbidities, only
ementia was signiﬁcantly associated with death in this pop-
lation (seven patients with dementia died, 100%, p = 0.009).
hese patients were not palliative, and treatment was not
onsidered futile by the medical staff. Table 2 presents data1 3;5  9(3):241–247 243
for survivor and non-survivor patients with CCI. Age, need for
neurosurgery, APACHE II score, and sepsis were signiﬁcantly
different between groups. Total hospital stay and costs did not
differ between survivors and non-survivors.
Fig. 1 shows daily records of mean SOFA in critically ill
patients, grouped according to survival status, and chronically
critically ill patients. A signiﬁcant difference emerged among
these three populations on day six (panel A). No differences
were found in SOFA scores between chronically critically ill
patients who survived and those who did not survive (panel
B).
A logistic regression was performed with CCI status as the
dependent variable. Based on the results of the bivariate analy-
ses (Table 1), variables were selected for the logistic regression
model if they were signiﬁcantly associated with the outcome
at a p-value of < 0.20. The ﬁnal model included the following
variables: abnormal BMI, MV in the ﬁrst four days, sepsis in
the ﬁrst four days, abnormal Glasgow score, and inadequate
caloric intake (for at least three days during the ﬁrst week
in the ICU). A ROC curve was constructed to assess the pre-
dictive accuracy of the model. The Hosmer and Lemeshow
goodness-of-ﬁt test showed that the model adequately ﬁt
the data (p = 0.788), with a good discriminative capacity (area
under ROC curve = 0.803). The inclusion of prior neuromuscu-
lar disease in combination with any four of the ﬁve predictive
parameters increased the speciﬁcity, but decreased the sensi-
tivity of the model.
Discussion
The main goal of this study was to identify the incidence
and the clinical characteristics of CCI in a general ICU, and
to identify early predictors of this condition. This popula-
tion has been deﬁned by different criteria,1,2,5,6,24,25 generally
involving dependence on mechanical ventilation.4,25 A chron-
ically critically ill patient is a patient who  depends on any
ICU support while staying in the ICU for an extended period.
CCI was mostly deﬁned by prolonged MV (84%), showing an
incidence of 11%, which is similar to that found in other
studies.6,14–16 No differences were found regarding gender or
age of patients who progressed to CCI compared to acute
patients; nevertheless, older age, sepsis, and higher APACHE
II scores were associated with increased mortality in the
CCI group, as shown in Table 2. There was no association
between previous chronic disease and CCI, with the excep-
tion of neuromuscular disease (such as paraplegia, muscular
atrophy, neurodegenerative disease, or sequelae of stroke).
This exception is not surprising, since it involves the mus-
cular system, which is at the core of CCI. Neuromuscular
dysfunction plays an important role in the pathogenesis of
muscle fatigue, a prevalent issue in chronically critically ill
patients.12
Tracheotomy was highly prevalent in this sample, and
reﬂects the difﬁculty in weaning these patients from MV.
Higher scores on APACHE II, a predictor of mortality, or on
SOFA, an index of severity, generally indicate more  seri-
ously ill patients and were associated with an increased risk
of developing a CCI (Table 1). Neurosurgery was more  fre-
quent in the CCI group. Possibly for this reason, an abnormal
244  r e v a s s o c m e d b r a s . 2 0 1 3;5  9(3):241–247
Table 1 – Baseline characteristics and outcome of chronically critically ill (CCI) and critically ill (CI) patients.
Results p-value
CCI (50) CI (403)
General characteristics
Age (years) 68 (± 18.4) 66.1 (± 17.2) 0.484
Male gender 21 (42%) 214 (53%) 0.138
Pre-ICU days 11.4  (± 30.8) 4.5 (± 10.9) 0.120
ICU total days 40.8  (± 24.2) 8.7 (± 18.0) < 0.001
ICU re-admission 5 (10%) 31 (7.7%) 0.577
Surgery 21 (42%) 151 (37.5%) 0.533
Neurosurgery 9 (18%) 33 (8.2%) 0.036
Pressure ulcers 26 (48.1%) 28 (6.9%) < 0.001
Adverse eventa 2 (4%) 9 (2.2%) 0.271
Scores
BMI (kg/m2) 25.2 (± 4.8) 22.3 (± 10.6) 0.002
BMI (kg/m2) ≥ 26 33 (67.3%) 160 (40%) < 0.001
APACHE II score 18.4 (± 6.1) 15.3 (± 6.9) 0.004
APACHE II predicted mortality 26.8% 16.7% < 0.001
SOFA score on day one 4.7 (± 2.7) 2.5 (± 2.8) < 0.001
Clinical scenarios
Hyperglycemiab on day one 10 (23.8%) 65 (15.8%) 0.184
Hyperglycemiab in the ﬁrst 96 h 4 (8%) 21 (5.2%) 0.505
Sepsis on day one 11 (26.2%) 56 (13.6%) 0.029
Sepsis in the ﬁrst 96 h 10 (23.8%) 43 (10.5%) 0.020
Glasgow < 15 on day one 26 (61.9%) 118 (28.7%) < 0.001
Glasgow < 15 in the ﬁrst 96 h 25 (59.5%) 87 (21.1%) < 0.001
Deliriumc 3 (7.1%) 38 (9.2%) 1.000
CPR day one to day eight 3 (7.1%) 8 (2.0%) 0.073
Therapies
Blood (packed red blood cell units) 3.8 (± 4.9) 0.6 (± 1.6) < 0.001
MV on day one 34 (68%) 101 (25.1%) < 0.001
MV in the ﬁrst 96 h 25 (50%) 50 (12.4%) < 0.001
Vasopressor/inotropic on day one 16 (32%) 80 (19.9%) 0.047
Vasopressor/inotropic in the ﬁrst 96 h 6 (12%) 39 (9.7%) 0.376
Intravenous sedation on day one 21 (42%) 51 (12.7%) < 0.001
Intravenous sedation in the ﬁrst 96 h 11 (22%) 24 (6.0%) 0.001
Corticosteroid on day one 6 (12%) 50 (12.4%) 0.934
Corticosteroid in the ﬁrst 96 h 6 (12%) 37 (9.2%) 0.453
Parenteral nutrition 4 (8%) 6 (5.1%) 0.486
Inadequate caloric intaked 7 (14%) 8 (2%) < 0.001
Outcomes
Hospital stay in days 86.5 (± 76.7) 24.7 (± 33.4) < 0.001
Coste 183.4 (± 158.7) 33.2 (± 35.7) < 0.001
ICU mortality 16 (32%) 47 (11.8%) < 0.001
Hospital mortality 28 (56%) 67 (16.6%) < 0.001
Data presented as mean ± standard deviation and absolute and relative frequencies.
CCI, chronic critical illness; CI, critical illness; ICU, intensive care unit; BMI, body mass index (kg/m2); APACHE II, Acute Physiology and Chronic
Health Evaluation II; APACHE II mortality, calculation of mortality prediction for the score; SOFA, sequential organ failure assessment; PN,
parenteral nutrition; Glasgow, neurological evaluation score; MV, mechanical ventilation; CPR, cardiopulmonary resuscitation.
a adverse event: urinary tract infection, loss of catheter, probe or drain, accidents related to procedures;
b blood glucose > 180 mg%;
c temporary disorder of the mental faculties with excitement, mental confusion, disorientation and/or hallucination;
d three or more days in the ﬁrst week with less than 60% of caloric intake relative to predicted need, and absence of gastric or intestinaldysfunction;
e mean per capita cost in thousands of US$.
Glasgow score was strongly associated with CCI. It should be
kept in mind that the sicker the patient, the greater the chance
of developing complications such as CCI. Thus, neurologi-
cal disorders and sepsis, which represent common etiologies
of severe illness, especially when concomitant, were signiﬁ-
cantly associated with CCI.Myopathy in critically ill patients has become a subject
of considerable interest in recent studies. It is related to
immobility, inﬂammation, prolonged sedation, and MV,26–29all of which are involved in CCI. Patients affected by CCI
often are not able to maintain sufﬁcient nutritional intake.
In the present study, daily nutritional intake was considered
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Table 2 – Clinical differences between survivor and non-survivor chronically critically ill patients.
CCI p-value
Survivors (21) Non-survivors (29)
Age (years) 58.2  (±16.3) 75.2 (±15.8) 0.001
Male gender 12 (57.1%) 11 (37.9%) 0.179
Pre-ICU days 6.3 (±19.1) 23.5 (±43.8) 0.068
Surgery 15 (71.4%) 10 (34.5%) 0.059
Neurosurgery 8 (38.1%) 4 (13.8%) 0.047
BMI (kg/m2) 26.1(±5.2) 26.3 (±4.8) 0.885
APACHE II score 15.5 (±5.3) 20.6 (±7.0) 0.007
SOFA score on day one 3.6 (±2.8) 5.0 (±2.7) 0.099
SOFA score on day two 4.1 (±3.0) 4.7 (±3.0) 0.448
SOFA score on day three 3.8 (±2.9) 4.5 (±2.7) 0.444
SOFA score on day seven 4. (±2.8) 3.7 (±2.9) 0.704
Hyperglycemiaa on day one 2 (9.5%) 9 (31%) 0.073
Hyperglycemiaa in the ﬁrst 96 h 1 (4.8%) 7 (24.1%) 0.117
Sepsis on day one 1 (4.8%) 13 (44.8%) 0.002
Sepsis in the ﬁrst 96 h 1 (4.8%) 11 (37.9%) 0.007
Glasgow score < 15 on day one 13 (61.9%) 19 (65.5%) 0.793
Glasgow score < 15 in the ﬁrst 96 h 13 (61.9%) 17 (58.6%) 0.815
Glasgow score < 10 on day one 5 (23.8%) 7 (24.1%) 0.979
CPR day one to day eight 2 (9.5%) 1 (3.4%) 0.565
Bloodb 3.7 (±4.3) 2.2 (±3.1) 0.136
VP-IT on day one 3 (14.3%) 12 (41.4%) 0.039
VP-IT in the ﬁrst 96 h 2 (9.5%) 5 (17.2%) 0.684
IV sedation on day one 11 (52.4%) 10 (34.5%) 0.206
IV sedation in the ﬁrst 96 h 6 (28.6%) 7 (24.1%) 0.724
Hospital stay in days 108.4 (±85.6) 107.6 (±111.5) 0.978
Costc 204.7 (±187.5) 166.8 (±133.1) 0.409
Data presented as mean ± standard deviation and absolute and relative frequencies.
CCI, chronic critical illness; ICU, intensive care unit; BMI, body mass index (kg/m2); CPR, cardiopulmonary resuscitation; VP-IT, vasopressor
and/or inotropic infusion; IV, intravenous.
a blood glucose > 180 mg%;
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nsufﬁcient when patients received less than 60% of the
lanned goal. There is much speculation concerning the link
etween malnutrition and poor healing of pressure ulcers30
nd muscle fatigue.31 A relatively higher supplementation
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ig. 1 – (Panel A) – Daily records of the total SOFA score between 
on-survivors (CI-NS). Note that the average cumulative change 
nsigniﬁcant (less than one point). When daily SOFA modiﬁcation
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OFA score.
CI, chronic critically ill; CI-S, critically ill survivor; CI-NS, criticalof essential (as compared to branched-chain amino acids)
has been shown to decrease proteolysis in patients with
myopathy.32 That practice is not regularly implemented at
Hospital Mãe de Deus, where muscle weakness and fatigue are
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frequently observed. Inadvertently reduced caloric intake is
associated with CCI (Table 1), and protocols to ensure adequate
nutrition to critically ill patients should be instituted.
On the sixth day, the daily SOFA score showed a difference
between CCI and non-CCI patients (Fig. 1A). However, the SOFA
score was not able to differentiate survivors and non-survivors
among chronically critically ill patients (Fig. 1B). According
to these data, APACHE II and SOFA scores, routinely used in
many  ICUs, could predict the likelihood of a lengthy stay in the
ICU. Honarmand et al.33 demonstrated that the SOFA score on
days zero, two, and four predicted the need for MV in surgical
patients, but not the amount of time on ventilatory support.
The fact that the SOFA score performed better in the present
study could be related to differences in the studied samples.
In the present study, the cumulative mean SOFA score did not
change signiﬁcantly during the ﬁrst days in chronically criti-
cally ill patients (variation of less than one point, Fig. 1). This
indicates that, in terms of organ dysfunction, neither worsen-
ing nor signiﬁcant improvement was observed over a week,
suggesting that the early therapy offered to these patients
should be readjusted. Thus, it could be argued that the initial
presentation is sufﬁcient to determine chronicity, but insuf-
ﬁcient to cause death. With time these conditions take their
toll, which explains the late mortality observed (Table 1).
APACHE II was used to predict hospital and ICU mortal-
ity rates. The observed and predicted ICU mortality rates
of critically ill patients were respectively 12.1% and 16.7%
(standardized mortality rate [SMR] 0.72, 95% CI: 0.54-0.95,
p = 0.0173). For patients with CCI, there was no increased mor-
tality in the ICU, contrary to the initial expectations. The
observed and predicted ICU mortality rates were 30.9% and
26.8%, respectively (SMR = 1.15, 95% CI: 0.64-1.92, p = 0.5917).
Regarding hospital mortality, we found, respectively, an
observed and predicted hospital mortality of chronically
critically ill patients of 52.4% and 26.8% (SMR = 2, 95% CI: 1.3-
2.9, p < 0.001), and for critical patients, of 17.8% and 16.7%
(SMR = 1.07, 95% CI: 0.8-1.3, p = 0.543). Thus, CCI could be
potentially associated with increased mortality. The present
population of chronically critically ill patients appears similar
to that of Estenssoro et al.,16 with a higher mortality rate occur-
ring later, suggesting that the effects of humoral, hormonal,
and neurological changes may extend over a long period of
time, including the period after hospitalization, which has
been described by others.2,9,14,19
CCI patients accounted for 11% of the total population
studied, and consumed 40.6% of the resources (Table 1). The
average cost per day for one CCI patient was US$ 2,121.00, com-
pared to US$ 1,347.00 for critical patients. The data suggest
that differentiating the management of ICU patients (early
recognition of the potential for chronic course, improvement
in motor rehabilitation processes, and adequacy of nutri-
tional support), reducing the incidence of CCI by 1%, and the
mean hospitalization for CCI patients by 10% could save US$
1,971,342.00 per year. The amount saved could be reinvested
in hiring human resources to implement protocols for this
population, to avoid ventilator-associated pneumonia, to pre-
vent sepsis, and for nutritional support, weaning from MV, and
mobilization.
For the logistic regression, all data were used in differ-
ent sets (grouping four or ﬁve parameters). Clinically relevant 0 1 3;5  9(3):241–247
parameters, earliest altered data, and statistical signiﬁcance
were always given priority in the model. Thus, it was pos-
sible to detect ﬁve variables that taken together predicted
early CCI: abnormal BMI, MV (ﬁrst four days), sepsis (ﬁrst
four days), abnormal Glasgow score (ﬁrst four days), and
inadequate nutrition in the ﬁrst week. Other compositions
of ﬁve variables, entering “previous neuromuscular disease”
in the multivariate model, were also signiﬁcant, albeit with
slightly lower sensitivity and higher speciﬁcity. These vari-
ables should be evaluated in larger, multicenter studies, to
analyze their reproducibility and accuracy in predicting CCI.
Moreover, these parameters should be the focus of different
treatment protocols to uncover strategies that could poten-
tially reduce the incidence of CCI, improve outcomes, and
reduce costs.
The present study has some limitations. Patients with CCI
who survived were not followed-up to monitor the outcome
over a long period after hospital discharge. Sleep or psychiatric
disorders were not assessed in this protocol, which could have
an impact on the course and outcome of CCI. Patient’s distress
and family burden were also not studied. Finally, this study
was only conducted at a single center.
Conclusions
The present data show the complex, serious, and fragile
nature of chronically critically ill patients. Early identiﬁca-
tion of these patients is crucial in order to apply a more
appropriate therapy, which requires improving the under-
standing and care of these patients. Abnormal BMI, MV, sepsis,
abnormal Glasgow score, and inadequate nutrition in the ﬁrst
week are common and early predictors. Among patients who
became CCI, older age and sepsis at admission were associ-
ated with increased mortality. Future studies should address
the impact of multidisciplinary management in maintaining
patient stability through individualized ventilatory support,
differentiated nutritional support, mobilization, and muscle
strengthening.
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